Agent | Dose/(mg/kg), schedule | Route | Mice | T/C (%) | T-C Days | Log 10kill | Cure |
---|---|---|---|---|---|---|---|
Control | Diluent, QD × 5 | i.v. | 8 | 100 | 0 | 0 | 0/8 |
Rituximab | 150 mg, QD × 5 | i.v. | 8 | 30 | 13 | 1.9 | 0/8 |
2-CdA | 30 mg, QD × 5 | s.c. | 8 | 36.9 | 14 | 1.33 | 0/8 |
(RTX + 2-CdA) | (150 + 30),QD × 5 | (i.v. + s.c.) | |||||
Diluent | Diluent, QD × 5 | i.v. | 8 | 16.9 | N/A | N/A | 8/8 |
(RTX + 2-CdA) | (150 + 30),QD × 5 | (i.v. + s.c.) |